Transesophageal echocardiography (TEE) in atrial fibrillation

Cardiology Clinics

Volumn 18, Issue 4, 2000, Pages 819-831

  Thamilarasan, Maran ^b   Klein, Allan L ^b   Youn, H J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; HEART ATRIUM FIBRILLATION; HUMAN; MULTICENTER STUDY; PATHOGENESIS; PATIENT CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SAFETY; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0034474717     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0733-8651(05)70182-x     Document Type: Review

References (69)

1. ACC/AHA consensus guidelines: Management of patients with atrial fibrillation
2. Assessment of Cardioversion Using Transesophageal Echocardiography investigators: Design of a clinical trial for the assessment of cardioversion using TEE (The ACUTE multicenter study): Steering and Publications Committees of the ACUTE study
3. Electrophysiologic mechanisms of perpetuation of atrial fibrillation
4. Atrial Fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials
5. The efficacy of anticoagulant therapy in preventing embolism related to DC electrical conversion of atrial fibrillation
6. Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation: A multicenter study
7. Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and flutter in nonanticoagulated patients
8. Left atrial spontaneous echo contrast: A clinical and echocardiographic analysis
9. Prevalence and clinical implications of atrial spontaneous echo contrast in patients undergoing transesophageal echocardiography
10. Cerebral Embolism Task Force: Cardiogenic brain embolism: The second report of the Cerebral Embolism Task Force
11. Cardioversion of nonrheumatic atrial fibrillation: Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus formation
12. Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation
13. Left atrial spontaneous echoes: Markers of thromboembolic risk in patients with atrial fibrillation
14. Echographic assessment of atrial transport, mitral movement and ventricular performance following electroversion of supraventricular arrhythmias
15. Transesophageal echocardiographic evaluation of left atrial appendage function and spontaneous contrast formation after chemical or electrical cardioversion of atrial fibrillation
16. Stratification of thromboembolic risk of atrial fibrillation by transthoracic echocardiography and transesophageal echocardiography: The relative role of left atrial appendage function, mitral valve disease, and spontaneous echocardiographic contrast
17. Relations between left atrial appendage blood velocity, spontaneous echo contrast and thromboembolic risk in vivo
18. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: Evidence for "atrial stunning" as a mechanism of thromboembolic complications
19. Prevalence, age distribution, and gender of patients with atrial fibrillation
20. Left atrial appendage Doppler flow patterns: Implications on thrombus formation
21. TEE-guided anticoagulation in patients undergoing electrical cardioversion of atrial fibrillation: Results from the ACUTE registry
22. Left atrial appendage "stunning" after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography
23. Left atrial appendage "stunning" after electrical cardioversion of atrial flutter: Attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events
24. Impact of electrical cardioversion for atrial fibrillation on left atrial appendage function and spontaneous echo contrast: Characterization by simultaneous transesophageal echocardiography
25. Influence of acutely altered loading conditions on left atrial appendage flow velocities
26. Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter: A prospective study using transesophageal echocardiography
27. Assessment of left atrial appendage function after cardioversion of atrial fibrillation: Relation to left atrial mechanical function
28. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echo cardiographic study
29. Pulsed Doppler characterization of left atrial appendage flow
30. Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation
31. Cost effectiveness of TEE-guided cardioversion with anticoagulation compared to conventional therapy in patients with atrial fibrillation
32. Cardioversion guided by transesophageal echocardiography: The ACUTE pilot study: A randomized, controlled trial: Assessment of Cardioversion Using Transesophageal Echocardiography
33. Integrated backscatter for quantification of left atrial spontaneous echo contrast
34. Left atrial thrombus detection with multiplane transesophageal echocardiography: An echocardiographic study with surgical verification
35. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Conference on Antithrombotic Therapy
36. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation
37. "Cardioversion" of atrial fibrillation: A report on the treatment of 65 episodes in 50 patients
38. Transesophageal echocardiographic prediction of initially successful electrical cardioversion of isolated atrial fibrillation: Effects of left atrial appendage function
39. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi
40. Impaired left atrial mechanical function after cardioversion: Relationship to the duration of atrial fibrillation
41. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final results of a prospective 4.5 year study
42. Atrial anatomy and function post cardioversion: Insights from transthoracic and transesophageal echocardiography
43. Accuracy of transesophageal echocardiography for identifying left atrial thrombi: A prospective, intraoperative study
44. Limitations of transesophageal echocardiography in the risk assessment of patients before nonanticoagulated cardioversion from atrial fibrillation and flutter: An analysis of pooled trials
45. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: Identification of a subgroup of patients at increased embolic risk
46. National use of the transesophageal echocardiography guided approach to cardioversion for patients in atrial fibrillation
47. Design of a study to assess a transesophageal echocardiography guided low-molecular-weight heparin (enoxaparin) antithrombotic strategy for cardioversion of patients in atrial fibrillation: The ACUTE II pilot study
48. Imaging of thrombi and assessment of left atrial appendage function: A prospective study comparing transthoracic and transesophageal echocardiography
49. Echocardiographic parameters for predicting maintenance of sinus rhythm after internal atrial defibrillation
50. Is left atrial appendage flow a predictor for outcome of cardioversion of nonvalvular atrial fibrillation?: A transthoracic and transesophageal echocardiographic study
51. Left atrial appendage dysfunction: A cause of thrombosis?: Evidence by transesophageal echocardiography-Doppler studies
52. Evaluation of left atrial appendage anatomy and function in recent-onset atrial fibrillation by transesophageal echocardiography
53. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: A transesophageal echocardiographic study
54. Cardioversion in patients with atrial fibrillation and left atrial thrombi on initial transesophageal echocardiography: Should transesophageal echocardiography be repeated before elective cardioversion?: A cost-effective analysis
55. Cost-effectiveness of transesophageal echocardiographic-guided cardioversion: A decision analytic model for patients admitted to the hospital with atrial fibrillation
56. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study
57. Transesophageal echocardiographic guidance of cardioversion in patients with atrial fibrillation
58. Stroke Prevention in Atrial Fibrillation III (SPAF III) investigators: Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III study: The SPAF III writing committee for the Stroke Prevention in Atrial Fibrillation Investigators
59. Stroke Prevention in Atrial Fibrillation Investigators: Predictors of thromboembolism in atrial fibrillation, I: Clinical features of patients at risk
60. Stroke Prevention in Atrial Fibrillation Investigators: Predictors of thromboembolism in atrial fibrillation, II: Echocardiographic features of patients at risk
61. Stroke Prevention in Atrial Fibrillation Investigators: Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation: The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography
62. Evaluation of left atrial appendage function by measurement of changes in flow velocity patterns after electrical cardioversion of patients with isolated atrial fibrillation
63. Clinical implications of left atrial spontaneous echo contrast in non-rheumatic atrial fibrillation
64. Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation
65. Transesophageal echocardiography facilitated conversion from atrial fibrillation: Short term safety and implications regarding maintenance of sinus rhythm
66. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study
67. Secular trends in the prevalence of atrial fibrillation: The Framingham Study
68. Duration of atrial fibrillation and imminence of stroke: The Framingham Study
69. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation